MLR Workflow Automation
Routing, roles, annotation, version control, cycle-time analytics.
SERIES 01 · DIMENSION 2 DEEP DIVE
Content Supply Chain & Compliance.
How pharma moves content from creation through Medical, Legal and Regulatory review to approved deployment, and where agentic AI is rewriting the bottleneck. Eight vendors scored across six sub-dimensions, every score carrying an evidence tier.
Agentic review does not remove the need for a governed content framework. It makes that framework the input the automation depends on.
Approval does not attach to fluency, it attaches to traceability. The moment a model rewrites an approved claim, the reference stops being the source and becomes an interpretation, and nobody signs an interpretation. That single fact shapes every score in this dimension: a model that assembles and verifies approved building blocks is worth more here than one that writes freely.
WHAT THIS DIMENSION COVERSSIX SUB-DIMENSIONS · SCORED 1 TO 5
Modular Content & Claims Management
Governed claims, references and modules with traceability.
Digital Asset Management
Versioned repository, metadata, rights, expiry, distribution.
AI-Assisted Review & Pre-Screening
Claims verification, reference checking, remediation.
Content Localisation & Market Adaptation
Global-to-local workflow and version tracking.
Regulatory Submission Support
eCTD, Form 2253, health-authority certification.
Three principles keep the scoring honest.
Evidence tiers and the anchor rule
Each score is graded on an evidence tier, and one rule governs the top of the scale: a 4 or 5 requires product documentation, release notes, an independent benchmark, or an independent analyst report. Capability described only in marketing caps at 3. This separates what a vendor claims from what actually ships.
Category participation, so like is compared with like
Vendors are classified by how they participate: Foundational, Add-on, or Services-led. A specialist that does not play in a sub-dimension is marked not applicable rather than scored 1, so a focused vendor is not penalised for being focused.
A European lens
Scoring prioritises what a DACH and Northern European buyer actually needs: EU or EEA data residency, GDPR coverage, named European references, and a position on the EU AI Act, which has governed AI-generated public-health content since 2 August 2026.
The questions a pharma leader is actually asking.
Each answered with scored evidence rather than vendor claims.
- 01What does AI MLR pre-approval really deliver, and where does the marketing story end and shipped capability begin?
- 02Flags versus prevents: what separates a basic pre-check that catches typos and branding from one that catches an unsupported claim or a broken reference?
- 03Does a 70 percent cut in manual MLR labour actually mean less total work, or does rising content volume quietly eat the saving?
- 04Buy, build, or train: is a domain-trained model a shortcut to compliant content, or a trap that makes accuracy worse?
- 05Who actually reviews content, and who merely delivers it? The two are easy to confuse and expensive to get wrong.
- 06What do the regulators require, and does a single vendor yet have a citable EU AI Act governance position?
- 07Which one decision should anchor a D2 stack, before any tool is chosen?
Read the scope or read the scores.
FREETeaser Edition
Scope and method.
What the dimension covers, the six sub-dimensions, how scoring works, and the questions the full report answers. Direct download, no form, no email gate.
Download the TeaserFULL REPORTEight vendors scored
The scores and the reasoning.
- The full scoring table for the Big Three and the specialists, each score carrying its evidence tier.
- A vendor-by-vendor read of who leads, who is catching up, and who is not ready.
- The agentic MLR trajectory: where the dimension is heading and what it means for a governed content framework.
- The regulatory frame (ABPI, PMCPA, EU AI Act, AIFA) and the single RFP question that matters most.
- Practical guidance: which system of record to pick first, and how to read a vendor claim against the evidence anchor.